Trump announces Medicaid drug pricing deals with 9 firms
Summary
President Donald Trump announced new agreements with nine biotechnology and pharmaceutical companies to lower drug prices for Medicaid programs. These deals ensure that Medicaid will pay the lowest prices available worldwide for the covered medicines.Key Facts
- The agreements involve nine midsize biotech and pharmaceutical companies.
- The deals apply to state Medicaid programs, which provide health coverage to low-income people.
- The companies agreed to offer their drugs at the lowest price they charge anywhere in the world.
- President Trump made the announcement in the Oval Office, with executives from the companies present.
- The goal is to reduce medication costs for Medicaid recipients.
- Medicaid is a government program that helps people pay for health care based on income.
- The agreements aim to make spending on drugs more affordable for states using Medicaid.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.